MedPath

A randomized controlled comparison of difference HR after the reversal of non-depolarized muscle relaxant with atropine 0.6 mg, 0.9 mg and 1.2 mg plus neostigmine 2.5 mg

Phase 4
Completed
Conditions
2 patients had delayed bradycardia
atropine&#44
heart rate&#44
reversal non&#45
depolarizing muscle relaxant
Registration Number
TCTR20161108003
Lead Sponsor
Khonkaen Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
87
Inclusion Criteria

1. Elective case for surgery undergo to general anesthesia and receive non - depolarizing muscle relaxant
2. ASA I-II
3. Age 18-65 year-old

Exclusion Criteria

1. underlying disease: Hypertension, hyperthyroidism, arrhythmia
2. Pregnancy
3. BMI>30

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
difference heart rate every 1 min for 15 min then 5 min for 90 min heart rate
Secondary Outcome Measures
NameTimeMethod
difference blood pressure every 1 min for 15 min then 5 min for 90 min blood pressure
© Copyright 2025. All Rights Reserved by MedPath